Name: Latest research reports of Piramal Pharma Ltd. authored by Motilal Oswal and published by - Trendlyne research reports.
Item: Piramal Pharma Ltd.
Rating: 5
Author: Motilal Oswal

Piramal Pharma Ltd.

NSE: PPLPHARMA | BSE: 543635 | ISIN: INE0DK501011 | Industry: Pharmaceuticals
| Falling Comet

151.1900 -0.22 (-0.15%)

NSE Jan 27, 2026 11:55 AM

New 52W Low in past week

Volume: 2.2M

Piramal Pharma Ltd.

25 Sep 2024

151.19

-0.15%

Geared to drive robust operating leverage across segments

Buy: Piramal Pharma Ltd.

Target

Motilal Oswal

PIRPHARM is well-positioned to offer differentiated services at the product development and commercial manufacturing stage in the CDMO segment.

Piramal Pharma has lost -25.29% in the last 3 Months